Thiazolidinedione treatment decreases oxidative stress in spontaneously hypertensive heart failure rats through attenuation of inducible nitric oxide synthase-mediated lipid radical formation

Diabetes

Volumn 61, Issue 3, 2012, Pages 586-596

  Kadiiska, Maria B ^a   Bonini, Marcelo G ^b   Ruggiero, Christine ^c   Cleland, Ellen ^c   Wicks, Shawna ^c   Stadler, Krisztian ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 NITROTYROSINE; 4 HYDROXYNONENAL; FREE RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; IN VIVO STUDY; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT;

ALDEHYDES; ANIMALS; BODY COMPOSITION; FREE RADICALS; GLUCOSE INTOLERANCE; HEART FAILURE; HYPERTENSION; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER; MALE; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; THIAZOLIDINEDIONES; TYROSINE;

EID: 84857382044     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1091     Document Type: Article

References (42)

1. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002;25:1177-1184 (Pubitemid 41071169)
2. Haffner SM. Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol 1999;84(1A):11J-14J (Pubitemid 29334854)
3. Osei K. Insulin resistance and systemic hypertension. Am J Cardiol 1999;84 (1A):33J-36J (Pubitemid 29334859)
4. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002;283:E413-E422 (Pubitemid 35230477)
5. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000;275: 9047-9054 (Pubitemid 30180265)
6. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002;277:1531-1537 (Pubitemid 34968910)
7. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002;16:1335-1347 (Pubitemid 34913306)
8. Marette A. Molecular mechanisms of inflammation in obesity-linked insulin resistance. Int J Obes Relat Metab Disord 2003;27(Suppl. 3):S46-S48 (Pubitemid 38019188)
9. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000;11:212-217 (Pubitemid 30603166)
10. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003;52:1-8 (Pubitemid 36042100)
11. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 1998;95:2498-2502 (Pubitemid 28145970)
12. Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 2001;7:1138-1143 (Pubitemid 33010023)
13. Fujimoto M, Shimizu N, Kunii K, Martyn JA, Ueki K, Kaneki M. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 2005;54:1340-1348 (Pubitemid 40586662)
14. Sugita H, Kaneki M, Tokunaga E, et al. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 2002;282:E386-E394 (Pubitemid 34654809)
15. Shimabukuro M, Ohneda M, Lee Y, Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 1997;100:290-295 (Pubitemid 27349075)
16. Sharma K, Danoff TM, DePiero A, Ziyadeh FN. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 1995;207:80-88
17. Ceriello A, Quagliaro L, D'Amico M, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002;51:1076-1082 (Pubitemid 34438352)
18. Bédard S, Marcotte B, Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J 1997;325:487-493 (Pubitemid 27338732)
19. Kapur S, Bédard S, Marcotte B, Côté CH, Marette A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 1997;46:1691-1700 (Pubitemid 27456399)
20. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000;97:1784-1789 (Pubitemid 30118520)
21. Torres SH, De Sanctis JB, de L Briceño M, Hernández N, Finol HJ. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 2004;181:419-427 (Pubitemid 38868192)
22. Szabó C, Zanchi A, Komjáti K, et al. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002;106:2680-2686 (Pubitemid 35364922)
23. Ceriello A, Mercuri F, Quagliaro L, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001;44:834-838 (Pubitemid 32642455)
24. Tannous M, Rabini RA, Vignini A, et al. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 1999;42:539-544 (Pubitemid 29196003)
25. Stadler K, Bonini MG, Dallas S, et al. Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radic Biol Med 2008;45:866-874
26. Morrison CD, Huypens P, Stewart LK, Gettys TW. Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity. Biochim Biophys Acta 2009;1792:409-416
27. Schneider C, Tallman KA, Porter NA, Brash AR. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem 2001;276:20831-20838
28. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008;283: 21837-21841
29. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128 (Pubitemid 121003917)
30. Awasthi YC, Sharma R, Cheng JZ, et al. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med 2003;24:219-230 (Pubitemid 36945022)
31. Fazio VM, Rinaldi M, Ciafrè S, Barrera G, Farace MG. Control of neoplastic cell proliferation and differentiation by restoration of 4-hydroxynonenal physiological concentrations. Mol Aspects Med 1993;14:217-228
32. Bartesaghi S, Peluffo G, Zhang H, Joseph J, Kalyanaraman B, Radi R. Tyrosine nitration, dimerization, and hydroxylation by peroxynitrite in membranes as studied by the hydrophobic probe N-t-BOC-l-tyrosine tert-butyl ester. Methods Enzymol 2008;441:217-236
33. Bartesaghi S, Wenzel J, Trujillo M, et al. Lipid peroxyl radicals mediate tyrosine dimerization and nitration in membranes. Chem Res Toxicol 2010; 23:821-835
34. Sato K, Kadiiska MB, Ghio AJ, et al. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J 2002;16:1713-1720 (Pubitemid 35340351)
35. Garvey EP, Oplinger JA, Furfine ES, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997;272:4959-4963 (Pubitemid 27090046)
36. An J, Muoio DM, Shiota M, et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 2004;10:268-274 (Pubitemid 38667617)
37. Knecht KT, Mason RP. In vivo spin trapping of xenobiotic free radical metabolites. Arch Biochem Biophys 1993;303:185-194 (Pubitemid 23199810)
38. Yue Qian S, Kadiiska MB, Guo Q, Mason RP. A novel protocol to identify and quantify all spin trapped free radicals from in vitro/in vivo interaction of HO(.-) and DMSO: LC/ESR, LC/MS, and dual spin trapping combinations. Free Radic Biol Med 2005;38:125-135 (Pubitemid 39626918)
39. Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol 2004;483:79-93 (Pubitemid 38056607)
40. Charbonneau A, Marette A. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes 2010;59:861-871
41. Carvalho-Filho MA, Ueno M, Hirabara SM, et al. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 2005;54:959-967 (Pubitemid 40446309)
42. Sugita M, Sugita H, Kaneki M. Increased insulin receptor substrate 1 serine phosphorylation and stress-activated protein kinase/c-Jun N-terminal kinase activation associated with vascular insulin resistance in spontaneously hypertensive rats. Hypertension 2004;44:484-489 (Pubitemid 39281500)